Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Mutant epidermal growth factor receptor in benign, borderline, and malignant ovarian tumors.

Clinical cancer research : an official journal of the American Association for Cancer Research - 1 Jun 2008

Steffensen Karina Dahl, Waldstrøm Marianne, Olsen Dorte Aalund, Corydon Thomas, Lorentzen Karen Axelgaard, Knudsen Hans Jørgen, Jeppesen Ulla, Brandslund Ivan, Jakobsen Anders

Abstract excerpt

PURPOSE: Dysfunction of the epidermal growth factor (EGF) complex is essential to the growth and development of many human tumors. Overexpression of the EGF receptor (EGFR) is a characteristic finding in a considerable number of solid tumors and often signalizes poor prognosis. There is a major disagreement among researchers about both the frequency and possible clinical importance of EGFR overexpression in...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Ovarian Neoplasms
Share to Aged

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Blotting, Western

Share to Electrophoresis, Polyacrylamide Gel

Share to ErbB Receptors

Share to Gene Expression

Share to Neoplasm Staging

Share to Polymerase Chain Reaction

Source

Identifiers

PMID: 18519753
DOI: 10.1158/1078-0432.CCR-07-4171

Genes

EGFR
EGF

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-08.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Mutant epidermal growth factor receptor in benign, borderline, and malignant ovarian tumors.PMID 18519753Read ↗

The status of epidermal growth factor receptor in borderline ovarian tumours.Semantic proximity Read ↗

Protein levels and gene expressions of the epidermal growth factor receptors, HER1, HER2, HER3 and HER4 in benign and malignant ovarian tumorsSemantic proximity Read ↗

Determination of BRAF V600E (VE1) protein expression and BRAF gene mutation status in codon 600 in borderline and low-grade ovarian cancers.Semantic proximity Read ↗

Mutations Within the Kinase Domain and Truncations of the Epidermal Growth Factor Receptor Are Rare Events in Bladder Cancer: Implications for TherapySemantic proximity Read ↗

Expression of cell regulatory proteins in ovarian borderline tumors.Semantic proximity Read ↗

EGFR and EGFRvIII expression in primary breast cancer and cell lines.Semantic proximity Read ↗

v-Raf murine sarcoma viral oncogene mutation status in serous borderline ovarian tumors and the effect on clinical behavior.Semantic proximity Read ↗

Germ line and somatic mutations of BRAF V599E in ovarian carcinoma.Semantic proximity Read ↗

Down-regulation of integrin alpha2 surface expression by mutant epidermal growth factor receptor (EGFRvIII) induces aberrant cell spreading and focal adhesion formation.Semantic proximity Read ↗

p53 gene mutation in human borderline epithelial ovarian tumors.Semantic proximity Read ↗

A case of loss of heterozygosity in the BRCA2 gene of a borderline ovarian tumor: case report and review of literature.Semantic proximity Read ↗

Mutation of K-ras protooncogene in human ovarian epithelial tumors of borderline malignancy.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.